Capital and Deals
Corgi’s $4B Valuation Marks Its Third Funding Round in Eight Weeks
Insurance startup Corgi has closed a reported $4 billion funding round, its third capital raise in eight weeks. The company's…
Section
Tag: venture-capital
NIKKEI 225
38,412.10
+0.84%
HANG SENG
18,765.40
-0.32%
SHCOMP
3,042.77
+0.21%
STI
3,318.92
+0.55%
Capital and Deals
Markets
Sources & Methods: DTW’s Editorial Standards and Research Practices
DTW's Markets coverage relies on regulatory filings, investor confirmations, and comparable analysis. We verify every valuation claim, attribute forecasts, and…
Capital and Deals
Three judges set to evaluate Australia’s next unicorn candidate at Stripe Tour Sydney
TechCrunch Startup Battlefield comes to Sydney on August 19 with three judges evaluating eight early-stage startups. The winner receives $15,000…
Markets
AI infrastructure costs force startups toward cheaper Chinese alternatives
Cost-conscious startups are adopting cheaper Chinese AI models as American alternatives become a growing operational expense, raising questions about performance…
Capital and Deals
Dimension Capital closes $800M third fund as science-compute startups attract record venture interest
Dimension Capital closed an $800 million third fund, 60% larger than its previous raise, as startups blending AI with biotech…
Capital and Deals
Colossal Biosciences in talks to raise at $20B–$30B valuation as de-extinction startup gains revenue
De-extinction startup Colossal Biosciences is seeking new capital at a $20B–$30B valuation, up from a $10.2B round last year. The…
Capital and Deals
Founders Fund names former OpenAI exec Ryan Beiermeister as partner
Founders Fund has named Ryan Beiermeister, the former OpenAI VP of Product Policy, as a new partner. She joins the…
Capital and Deals
Silicon Valley’s Rich and Retired Are Taking Rank-and-File AI Jobs
Proven founders like Monzo's Tom Blomfield and Chamath Palihapitiya are returning to hands-on AI work, some taking a title Anthropic…
Capital and Deals
Greylock Caps New Fund at $1.5B, Betting Small Beats Big in Venture
Greylock closed an $1.5B fund it says could have been several times larger, choosing restraint to keep its portfolio to…
Capital and Deals
Reed Jobs’s Yosemite Chases $350M Second Fund as AI Reshapes Cancer Drug Economics
Reed Jobs's oncology-only firm Yosemite is closing a $350M second fund, building a third of its companies from scratch as…